Home › Funds › Humankind Investments LLC › BMRN
Humankind Investments LLC position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
Humankind Investments LLC reported holding 19,800 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.47% of its reported portfolio and ranking #20 among its reported holdings. Humankind Investments LLC has disclosed BMRN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Humankind Investments LLC's BMRN position evolved
Humankind Investments LLC first disclosed a stake in BMRN in Q1 2026 at 19,800 shares (US$1.1M). The position peaked in Q3 2026 at 19,800 shares, worth US$1.2M. Across 3 filings, Humankind Investments LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 19,800 shares valued at US$1.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 19.80K | $1.12M | New |
| Q2 2026 | 19.80K | $1.13M | Hold |
| Q3 2026 | 19.80K | $1.19M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMRN and 13F data
BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMRN
- PRIMECAP MANAGEMENT CO/CA/ 14.99M sh · $899.34M · Q3 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.62M sh · $435.82M · Q2 2026
- Deep Track Capital, LP 6.37M sh · $382.46M · Q3 2026
- Vestal Point Capital, LP 6.03M sh · $344.75M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M sh · $108.89M · Q2 2026
More on Humankind Investments LLC
FAQ
How long has Humankind Investments LLC held BMRN?
Humankind Investments LLC has disclosed BMRN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Humankind Investments LLC's current position in BMRN?
As of Q3 2026, Humankind Investments LLC holds 19.80K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $1.19M, representing 0.47% of its reported portfolio and ranking #20.
Has Humankind Investments LLC been buying or selling BMRN?
In the latest 13F filing (Q3 2026), Humankind Investments LLC held unchanged its position in BMRN. The position peaked in Q3 2026 at 19.80K shares.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.